European Archives - Page 118 of 1139 - European Medical Journal

Lupus nephritis drug delivers promising results, says Roche

Obinutuzumab could reshape the treatment of lupus nephritis, a life-threatening complication of lupus that has long lacked effective options.

Promising Stroke Treatment: Butylphthalide Slows Cognitive Decline

Butylphthalide reduces cognitive decline in stroke survivors over 12 months, offering promising neuroprotection for post-stroke care.

Immune Checkpoint Inhibitor Before Allogeneic Transplant Boosts Survival in Hodgkin Lymphoma

ICI treatment before transplant enhances survival in relapsed Hodgkin lymphoma, though it increases the risk of acute GVHD.

Sugary Drinks May Increase Diabetes Risk via Gut Microbiome

Researchers have shown that sugary drink intake affects diabetes risk via gut microbiome.

NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment

The newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

EMJ Innovations 9 [Supplement 1] 2025

In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient with faricimab resulted in…

Reverse Clinical Signs of Ageing
with Epigenetic Skin Science

Join leading dermatologists and epigenetics researchers Frank Lyko, Firas Al-Niaimi, Hassan Galadari, Elke Grönniger, and Julia Gallinger…

Lungs

Qureight and Avalyn unite to advance pulmonary fibrosis treatment

Two companies have come together to enhance the way imaging technology is used to assess treatment responses in progressive pulmonary fibrosis.

New Risk Score Uses Stress Levels to Improve Heart Disease Prediction

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

Optic Neuropathy Concerns with Popular Antidiabetic Drugs

Ophthalmic complications linked to semaglutide and tirzepatide raise concerns for diabetic patients on these medications.